glp-1 obesity drug news today New research is challenging long-held assumptions about drugs in weight loss treatments. A different approach may be emerging. Click the link in bio to read the full story Does stopping GLP-1s make you
Description
Renal protective effect of dpp-4 inhibitors in type 2 diabetes mellitus patients: a cohort study
[DOI] [PubMed] [Google Scholar] 66.Sommer CA, Mostoslavsky G (2014) RNA-Seq analysis of enteroendocrine cells reveals a role for FABP5 in the control of GIP secretion
A., Wong, C
These are designed to control blood sugar and also help regulate weight by reducing hunger pangs and food intake
Reduced Stability and PH-Dependent Activity of a Common Obesity-Linked PCSK1 Polymorphism, N221D. Endocrinology, vol
Notably, we found a significant increase in nausea events among participants receiving GLP-1RAs compared to those treated with metformin or placebo
